Cardiac Resynchronization Therapy Market 2033: 6.3% CAGR of Life-Saving Tech
Cardiac Resynchronization Therapy Market Summary The global cardiac resynchronization therapy (CRT) market size was valued at USD 4.74 billion in 2024 and is expected to reach USD 8.21 billion by 2033, registering a CAGR of 6.3% from 2025 to 2033. Growth is primarily driven by the increasing prevalence of heart failure and conduction abnormalities, rising adoption of advanced implantable cardiac devices, and expanding clinical evidence confirming the effectiveness of CRT in improving patient survival rates and overall quality of life. Technological innovations—including conduction system pacing (CSP), left bundle branch area pacing (LBBAP), and next-generation leadless or wireless CRT systems—are improving device accuracy and reducing procedural risks, which is contributing to broader adoption among cardiologists. Favorable reimbursement structures, increasing awareness of early intervention for heart failure, and greater use of AI-enabled remote monitoring platforms are ...